The efficacy of medical treatment in patients with acromegaly in clinical practice-Reference-Cited by-同舟云学术

The efficacy of medical treatment in patients with acromegaly in clinical practice

Published:2018 Issue:1 Volume:65 Page:33-41
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Lee Seo Young¹,Kim Jung Hee¹²,Lee Ji Hyun¹,Kim Yong Hwy²³,Cha Hyang Jin¹,Kim Sang Wan¹⁴,Paek Sun Ha¹²,Shin Chan Soo¹²

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

2. Pituitary Center, Seoul National University College of Medicine, Seoul, Republic of Korea

3. Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea

4. Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/1/65_EJ17-0125/_pdf

Reference34 articles.

1. 1 Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, et al. (2010) Mortality in patients with pituitary disease. Endocr Rev 31: 301–342.

2. 2 Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, et al. (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95: 3141–3148.

3. 3 Clayton RN (1997) New developments in the management of acromegaly. Should we achieve absolute biochemical cure? J Endocrinol 155 Suppl 1: S23–S29; discussion S31–S32.

4. 4 Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW (2003) Long-term treatment outcome in acromegaly. Growth Horm IGF Res 13: 185–192.

5. 5 Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, et al. (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99: 3933–3951.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22

2. Medical Treatment Landscape for Active Acromegaly in A Pituitary Center in Israel;Endocrine Practice;2020-11

3. Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus;Journal of Feline Medicine and Surgery;2020-07-20

4. OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists;Molecular Pharmaceutics;2020-04-28

5. Treatment of Pituitary and Other Tumours with Cabergoline: New Mechanisms and Potential Broader Applications;Neuroendocrinology;2019-10-10